21 CFR 314.540 – Postmarketing safety reporting
Current as of: 2024 | Check for updates
|
Other versions
Drug products approved under this program are subject to the postmarketing recordkeeping and safety reporting applicable to all approved drug products, as provided in §§ 314.80 and 314.81.
